H19 and breast carcinoma: The expression of H19 was found to be highly up-regulated in paclitaxel induced ERα-positive resistant breast cancer cell lines MCF-7R and ZR-75-1 (by ∼9-fold and 4-fold, respectively) compared to their parental lines MCF-7S and ZR-75-1S [17].